Nutrients,
Journal Year:
2021,
Volume and Issue:
13(8), P. 2559 - 2559
Published: July 26, 2021
In
COVID-19
patients,
low
serum
vitamin
D
(VD)
levels
have
been
associated
with
severe
acute
respiratory
failure
and
poor
prognosis.
regular
hemodialysis
(HD)
there
is
VD
deficiency
markedly
reduced
calcitriol
levels,
which
may
predispose
them
to
worse
outcomes
of
infection.
Some
patients
receive
treatment
drugs
for
secondary
hyperparathyroidism,
well
known
pleiotropic
effects
beyond
mineral
metabolism.
The
aim
this
study
was
evaluate
the
impact
status
administration
active
medications,
used
treat
on
survival
in
a
cohort
positive
HD
patients.
Reviews in Endocrine and Metabolic Disorders,
Journal Year:
2021,
Volume and Issue:
23(2), P. 265 - 277
Published: July 29, 2021
Abstract
Vitamin
D,
best
known
for
its
role
in
skeletal
health,
has
emerged
as
a
key
regulator
of
innate
immune
responses
to
microbial
threat.
In
cells
such
macrophages,
expression
CYP27B1,
the
25-hydroxyvitamin
D
1α-hydroxylase,
is
induced
by
immune-specific
inputs,
leading
local
production
hormonal
1,25-dihydroxyvitamin
(1,25D)
at
sites
infection,
which
turn
directly
induces
genes
encoding
antimicrobial
peptides.
signaling
active
upstream
and
downstream
pattern
recognition
receptors,
promote
front-line
responses.
Moreover,
1,25D
stimulates
autophagy,
mechanism
critical
control
intracellular
pathogens
M.
tuberculosis
.
Strong
laboratory
epidemiological
evidence
links
vitamin
deficiency
increased
rates
conditions
dental
caries,
well
inflammatory
bowel
diseases
arising
from
dysregulation
handling
intestinal
flora.
also
cascades
that
antiviral
immunity;
1,25D-induced
peptide
CAMP/LL37,
originally
characterized
antibacterial
properties,
component
Poor
status
associated
with
greater
susceptibility
viral
infections,
including
those
respiratory
tract.
Although
severity
COVID-19
pandemic
been
alleviated
some
areas
arrival
vaccines,
it
remains
important
identify
therapeutic
interventions
reduce
disease
mortality,
accelerate
recovery.
This
review
outlines
our
current
knowledge
mechanisms
action
system.
It
provides
an
assessment
potential
supplementation
infectious
diseases,
up-to-date
analysis
putative
benefits
ongoing
crisis.
The Journal of Clinical Endocrinology & Metabolism,
Journal Year:
2021,
Volume and Issue:
107(5), P. 1484 - 1502
Published: Dec. 11, 2021
Abstract
Purpose
Vitamin
D
deficiency/insufficiency
may
increase
the
susceptibility
to
coronavirus
disease
2019
(COVID-19).
We
aimed
determine
association
between
vitamin
and
COVID-19,
its
severity,
mortality,
role
of
in
treatment.
Methods
searched
CINAHL,
Cochrane
library,
EMBASE,
PubMED,
Scopus,
Web
Science
up
May
30,
2021,
for
observational
studies
on
severe
disease,
death
among
adults,
and,
randomized
controlled
trials
(RCTs)
comparing
treatment
against
standard
care
or
placebo,
improving
severity
mortality
adults
with
COVID-19.
Risk
bias
was
assessed
using
Newcastle-Ottawa
scale
AUB-KQ1
tool
RCTs.
Study-level
data
were
analyzed
RevMan
5.3
R
(v4.1.0).
Heterogeneity
determined
by
I2
sources
explored
through
prespecified
sensitivity
analyses,
subgroup
meta-regressions.
Results
Of
1877
search
results,
76
satisfying
eligibility
criteria
included.
Seventy-two
included
meta-analysis
(n
=
1
976
099).
increased
odds
developing
COVID-19
(odds
ratio
[OR]
1.46;
95%
CI,
1.28-1.65;
P
<
0.0001;
92%),
(OR
1.90;
1.52-2.38;
81%),
2.07;
1.28-3.35;
0.003;
73%).
The
25-hydroxy
concentrations
lower
individuals
compared
controls
(mean
difference
[MD]
-3.85
ng/mL;
-5.44
-2.26;
≤
0.0001),
patients
nonsevere
(MD
-4.84
-7.32
-2.35;
0.0001)
nonsurvivors
survivors
-4.80
-7.89
-1.71;
0.002).
insignificant
when
high
risk
reporting
unadjusted
effect
estimates
excluded.
heterogeneity
across
all
analyses.
Discrepancies
timing
testing,
definitions
partly
explained
heterogeneity.
Four
RCTs
widely
heterogeneous
precluding
meta-analysis.
Conclusion
Multiple
involving
nearly
2
million
suggest
increases
although
a
Association
less
robust.
precluded
their
Nutrition Reviews,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 9, 2025
This
systematic
review
(SR)
highlights
principles
for
nutrient
clinical
trials
and
explore
the
diverse
physiological
functions
of
vitamin
D
beyond
its
traditional
role
in
musculoskeletal
system
related
to
study
designs.
Thousands
published
research
articles
have
investigated
benefits
(a
example
taken
this
SR)
system,
including
immune,
pulmonary,
cardiovascular
systems;
pregnancy;
autoimmune
disorders;
cancer.
They
illustrated
D's
molecular
mechanisms,
interactions,
genomic
nongenomic
actions.
SR
was
designed
identify
shortcomings
designs,
statistical
methods,
data
interpretation
that
led
inconsistent
findings
D-related
publications.
also
examples
insights
into
avoiding
design
errors
future
studies,
randomized
controlled
(RCTs).
The
adheres
latest
PRISMA
statement,
guidelines,
PICOS
process.
Inappropriate
or
flawed
designs
were
frequent
trials.
Major
failures
discussed
here
include
too
short
duration,
inadequate
infrequent
doses,
insufficient
power,
failure
measure
baseline
achieved
levels,
recruiting
D-sufficient
participants.
These
misleading
interpretations.
Thus,
conclusions
from
such
studies
should
not
be
generalized
used
recommendations,
policymaking.
Adequately
powered
epidemiological
RCTs
with
sufficient
duration
individuals
deficiency
reported
favorable
outcomes,
enriching
literature,
enabling
understand
physiology
mechanisms.
Proper
rigorous
methodologies
cautious
outcomes
are
crucial
advancing
field.
apply
only
D,
but
other
micro-nutrients
nutraceutical
research.
Adhering
them
enhances
credibility
reliability
trials,
SRs,
meta-analysis
outcomes.
emphasizes
importance
focused,
hypothesis-driven,
well-designed,
statistically
nutrients,
conducted
index
deficient
participants,
avoidance
errors.
Findings
incorporated
practice,
policymaking,
public
health
improving
nation
reducing
healthcare
costs.
Nutrients,
Journal Year:
2021,
Volume and Issue:
13(6), P. 1760 - 1760
Published: May 21, 2021
Context.
Calcifediol
has
been
proposed
as
a
potential
treatment
for
COVID-19
patients.
Objective:
To
compare
the
administration
or
not
of
oral
calcifediol
on
mortality
risk
patients
hospitalized
because
COVID-19.
Design:
Retrospective,
multicenter,
open,
non-randomized
cohort
study.
Settings:
Hospitalized
care.
Patients:
Patients
with
laboratory-confirmed
between
5
February
and
May
2020
in
five
hospitals
South
Spain.
Intervention:
received
(25-hydroxyvitamin
D3)
(0.266
mg/capsule,
2
capsules
entry
then
one
capsule
day
3,
7,
14,
21,
28)
not.
Main
Outcome
Measure:
In-hospital
during
first
30
days
after
admission.
Results:
A
total
537
were
(317
males
(59%),
median
age,
70
years),
79
(14.7%)
treatment.
Overall,
in-hospital
was
17.5%.
The
OR
death
receiving
(mortality
rate
5%)
0.22
(95%
CI,
0.08
to
0.61)
compared
such
20%;
p
<
0.01).
who
admission
more
likely
than
those
have
comorbidity
lower
CURB-65
score
pneumonia
severity
≥
3
(one
point
each
confusion,
urea
>
7
mmol/L,
respiratory
30/min,
systolic
blood
pressure
90
mm
Hg
diastolic
≤
60
Hg,
age
65
acute
distress
syndrome
(moderate
severe),
c-reactive
protein,
chronic
kidney
disease,
nitrogen.
In
multivariable
logistic
regression
model,
adjusting
confounders,
there
significant
differences
it
(OR
=
0.16
CI
0.03
0.80).
Conclusion:
Among
COVID-19,
calcifediol,
significantly
associated
days.
observational
design
sample
size
may
limit
interpretation
these
findings.
Nature Reviews Cardiology,
Journal Year:
2021,
Volume and Issue:
19(5), P. 314 - 331
Published: Dec. 6, 2021
The
lungs
are
the
primary
target
of
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
infection,
with
hypoxia
being
cause
death
in
most
critical
cases.
Coronavirus
disease
2019
(COVID-19)
is
extremely
heterogeneous
terms
severity,
clinical
phenotype
and,
importantly,
global
distribution.
Although
majority
affected
patients
recover
from
many
continue
to
suffer
late
sequelae
affecting
various
organs,
including
lungs.
role
pulmonary
vascular
system
during
and
chronic
stages
COVID-19
has
not
been
adequately
studied.
A
thorough
understanding
origins
dynamic
behaviour
SARS-CoV-2
virus
potential
causes
heterogeneity
essential
for
anticipating
treating
disease,
both
stages,
development
hypertension.
Both
hypertension
have
assumed
dimensions,
complex
interactions.
In
this
Review,
we
present
an
update
on
discuss
COVID-19.
addition,
summarize
pathobiology
COVID-19,
emphasis
vasculature,
stage
developing
We
hope
that
information
presented
Review
will
help
strategies
prevention
treatment
continuing
pandemic.
Scientific Reports,
Journal Year:
2022,
Volume and Issue:
12(1)
Published: Nov. 12, 2022
Abstract
Vitamin
D
deficiency
has
long
been
associated
with
reduced
immune
function
that
can
lead
to
viral
infection.
Several
studies
have
shown
is
increases
the
risk
of
infection
COVID-19.
However,
it
unknown
if
treatment
reduce
COVID-19
infection,
which
focus
this
study.
In
population
US
veterans,
we
show
2
and
3
fills
were
reductions
in
28%
20%,
respectively
[(D
Hazard
Ratio
(HR)
=
0.80,
[95%
CI
0.77,
0.83]),
HR
0.72,
0.65,
0.79]].
Mortality
within
30-days
was
similarly
33%
lower
25%
(D
0.67,
0.59,
0.75];
0.75,
0.55,
1.04]).
We
also
find
after
controlling
for
vitamin
blood
levels,
veterans
receiving
higher
dosages
obtained
greater
benefits
from
supplementation
than
dosages.
Veterans
levels
between
0
19
ng/ml
exhibited
largest
decrease
following
supplementation.
Black
received
White
veterans.
As
a
safe,
widely
available,
affordable
treatment,
may
help
severity
pandemic.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(4), P. 3586 - 3586
Published: Feb. 10, 2023
Vitamin
D
is
necessary
for
the
normal
functioning
of
many
organs,
including
thyroid
gland.
It
is,
therefore,
not
surprising
that
vitamin
deficiency
considered
a
risk
factor
development
disorders,
autoimmune
diseases
and
cancer.
However,
interaction
between
function
still
fully
understood.
This
review
discusses
studies
involving
human
subjects
(1)
compared
status
(primarily
determined
by
serum
calcidiol
(25-hydroxyvitamin
[25(OH)D])
levels)
with
assessed
stimulating
hormone
(TSH),
hormones,
anti-thyroid
antibody
levels;
(2)
evaluated
effect
supplementation
on
function.
Due
to
inconsistencies
in
results
studies,
it
difficult
draw
definite
conclusion
how
affects
Studies
healthy
participants
observed
either
negative
correlation
or
no
association
TSH
25(OH)D
levels,
while
hormones
showed
high
variability.
Many
have
antibodies
but
equally
failed
observe
such
an
association.
Regarding
examined
function,
almost
all
decrease
levels
after
supplementation.
Factors
could
contribute
variability
are
use
different
assays
measurement
confounding
effects
sex,
age,
body-mass
index,
dietary
habits,
smoking,
time
year
when
samples
were
collected.
In
conclusion,
additional
larger
numbers
needed
understand
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(23), P. 15188 - 15188
Published: Dec. 2, 2022
Evidence
from
studies
in
the
general
population
suggests
an
association
between
vitamin
D
insufficiency/deficiency
and
COVID-19
susceptibility
disease
severity.
The
present
study
was
performed
on
165
third-trimester
pregnant
women
at
time
of
delivery.
Seventy-nine
tested
negative
for
SARS-CoV-2.
From
86
testing
positive,
32
were
asymptomatic,
44
presented
a
mild
form
disease,
10
experienced
severe
symptoms.
Serum
25-OH
levels
measured
blood
samples
collected
admission.
Low
detected
symptomatic
but
not
asymptomatic
patients
compared
to
healthy
(
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(2), P. 1305 - 1305
Published: Jan. 21, 2024
Vitamin
D
is
known
to
have
a
positive
effect
on
bone
health.
Despite
the
greater
frequency
of
vitamin
deficiency
in
African
Americans
(AA),
they
higher
mineral
density
(BMD)
compared
whites,
demonstrating
disconnect
between
BMD
and
levels
AA.
Another
intriguing
relationship
seen
AA
triglyceride
(TG)
paradox,
an
unusual
phenomenon
which
normal
TG
status
observed
even
when
patients
house
conditions
be
characterized
by
high
levels,
such
as
Type
II
diabetes.
To
best
our
knowledge,
no
study
has
examined
whether
these
two
paradoxical
relationships
exist
simultaneously
subjects
with
In
this
study,
we
blood
markers,
including
HbA1c,
TG,
D,
measured
serum
25-hydroxyvitamin
[25(OH)VD]
µM/mL,
[25(OH)VD]/TG,
calcium,
(n
=
56)
white
26)
diabetes
see
concurrently.
We
found
that
had
significantly
lower
subjects,
ages,
BMI,
duration
diabetes,
calcium
were
similar
groups.
This
demonstrates
diabetic
subjects.
addition
findings,
discuss
current
hypotheses
literature
attempt
explain
why
exist.
review
also
discusses
four
novel
hypotheses,
altered
circulating
potential
role
estrogen
hydrogen
sulfide
HMG-CoA
reductase
possible
contributor
paradox
manuscript
there
are
still
many
unanswered
questions
regarding
further
research
needed
determine
how
can
implemented
improve
healthcare.